• Zebrafish Tumor Models
  • Zebrafish Ocular Disease Models
  • Zebrafish Cardiovascular Disease Models
  • Zebrafish Neurological Disorder Models
  • Zebrafish Infectious Disease Models
  • Zebrafish Metabolic Disease Models
  • Zebrafish Liver Disease Models
  • Zebrafish Kidney Disease Models
  • Zebrafish Hematological Disease Models
  • Zebrafish Inflammation Disease Models
  • Zebrafish Skeletal Disease Models
  • Zebrafish Regeneration Models
  • Zebrafish Hearing-Related Disease Models
  • Zebrafish Arrhythmia Models

    Zebrafish Arrhythmia Models

    Spontaneous arrhythmias have proven difficult to model in vivo, in part because of our incomplete understanding of the etiology of most clinical rhythm disturbances. A variety of factors, including genetic susceptibility, extrinsic injury, environmental exposure, and stochastic processes, contribute to the eventual arrhythmia. An ideal animal model recapitulates not only the individual components of the causal chain leading to arrhythmias, but also every step of the process. Despite the large number of animal models, several areas of in vivo electrophysiology remain relatively inaccessible, including: developmental patterns of cardiac excitability and coupling, in vivo cell biology and efficient identification of channel partner proteins.

    Over the past decade, the zebrafish has emerged as a major genetic model organism that replicates human cardiac diseases, including arrhythmias, in vivo. The potential of zebrafish for in vivo cell biology, physiology, disease modeling, and drug discovery has begun to be realized. Zebrafish phenotypes can be easily identified, which has led to their use in many genetic and chemical screens. Additionally, zebrafish are able to survive for days without any cardiovascular function by diffusion alone, enabling screening for extreme phenotypes.

    Fig.1 Stages of cardiac development in zebrafish from 10 to 96 hours post-fertilization (hpf).Fig.1 Stages of cardiac development in zebrafish from 10 to 96 hours post-fertilization (hpf).

    Our Zebrafish Arrhythmia Models

    Creative Biogene has established a variety of zebrafish arrhythmia models through genetic manipulation. We combine rapid genetic manipulation and high-resolution physiology to define the endocardial signaling required to pattern central slow conducting tissue, helping you uncover distinct local endocardial-myocardial interactions within the developing heart tube for arrhythmia Disease initiation and pathogenesis provide unique insights. Thus, in addition, our zebrafish model can be used for inhibitory screening to identify novel chemical modulators of disease phenotypes or novel arrhythmogenic substrates.

    Table 1 Zebrafish models of cardiac arrhythmia.

    GeneAlleleCardiac DefectClinical ArrhythmiaHuman Ortholog
    atp1a1a.1hiphop (tx218)3:1 ratio of atrial contraction to ventricular contraction, bradycardia, and AV-block.LQTSATP1A1
    cacna1cisland beat (m379, m458, m231)Silent ventricle, uncoordinated contraction of the atrium.AFCACNA1C
    cmlc1s977Bradycardia, slow conduction in enlarged atrium, sarcomere disorganization.AFMYL4
    cx43 (gja1b)MorpholinoBradycardia, AV-block, and
    fibrillation.
    AFGJA1
    foxn4slipjig (s644)Peristaltic contraction with no AV delay.FOXN4
    gja3/cx46dococ (s215, s226)Uncoordinated conduction and contraction within the ventricle.CX46
    hcn4MorpholinoBradycardia and prolonged cardiac pauses.SSSHCN4
    isl1 (K88X mutant)sa00292 dpf: bradycardia due to impaired SA node function. 3–4 dpf: sinus blockSSSISL1
    kcnh6a (zerg)breakdance (tb218)2:1 ratio of atrial to ventricular contraction, bradycardia, reduced cardiac output, and AV-block due to impairment of IKr channelLQTSKCNH6 (hERG)
    kcnh6a (zerg)reggaeIntermittent atrial fibrillation and acceleration of cardiomyocyte repolarizationSQTSKCNH6 (hERG)
    kcnma1bMorpholinoDecreased contraction of heart chambers, sinus bradycardia.AFKCNMA1
    mcula2446Cardiomyopathy. Thin, dilated atrium, small ventricle with restricted blood flow, swollen mitochondria. Heart rate variability.SSSMCU
    nkx2.5vu176, vu413Reduced heart rate variation, increased heart rate.CHDNKX2-5
    pitx2cups6Embryonic: arrhythmia, sarcomere disorganization, increased ROS. Adult: extended P-wave and PR-interval, fibrosis, sarcomere disorganization.AFPITX2
    Scn5aHuman variantBradycardia, sinus pauses, AV-block.LQTSSCN5A
    slc8a1a
    (ncx1)
    tremblor (tc318d, te381b, m116, m139, m158, m276, m736)Fibrillation from onset of contraction (more prominent in the atrium than the ventricle). Absent circulation.SLC8A1
    (NCX1)
    tbx5aheartstrings (m21)Slight bradycardia evident during initial heart tube stage. Heart fails to loop, contractility declines, and
    pericardial edema develops.
    Holt–Oram syndromeTBX5
    tcf2hobgoblin (s634)AV block at 48 hpf,
    silent ventricle at 96 hpf.
    TCF2
    tmem161bgrime (uq4ks)Bradycardia, skipped ventricular beats, increased heart rate variabilityLQTSTMEM161B
    ttn.2sfc9Atrial fibrosis, compromised
    sarcomere assembly in atrium and ventricle, lengthened PR interval.
    AFTTN

    Advantages

    • Dynamic monitoring of various cellular processes in vivo by real-time imaging of fluorescent reporter lines
    • Fluorescent markers highlight the location or activity of specific cell populations
    • Ability to screen for extreme phenotypes
    • High-throughput genetic and drug screening

    References

    1. Gauvrit S, et al. Modeling Human Cardiac Arrhythmias: Insights from Zebrafish. J Cardiovasc Dev Dis. 2022, 9(1):13.
    2. Milan DJ, Macrae CA. Zebrafish genetic models for arrhythmia. Prog Biophys Mol Biol. 2008, 98(2-3):301-308.

    For research use only. Not intended for any clinical use.

    Quick Inquiry